FDA Approved: SKLICE — Supplemental Application (Azurity Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for SKLICE (ivermectin) by Azurity Pharmaceuticals to authorize changes related to the product's use/approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pediculosis Capitis

Drugs mentioned

• SKLICE (ivermectin)

Snippet

SUPPL AP for SKLICE (IVERMECTIN)